Effect of receptor phosphorylation on the binding between IRS‐1 and IGF‐1R as revealed by surface plasmon resonance biosensor

A receptor binding assay based on the surface plasmon resonance (SPR) biosensor technique was developed to study the interaction between insulin‐like growth factor‐1 receptor (IGF‐1R) and its intracellular substrate protein insulin receptor substrate‐1 (IRS‐1). The sensor surface was modified with anti‐IGF‐1R (α‐subunit) monoclonal antibodies for the capturing of the receptor‐containing membrane fragments from cell lysates. The IGF‐1R was successfully immobilized on the sensor surface with binding capability for its intracellular substrates. SPR measurements showed that the tyrosine phosphorylation of IGF‐1R induced by its extracellular ligand insulin‐like growth factor‐1 caused the receptor to bind with IRS‐1 10 times faster than the unactivated receptor. As a result, the affinity constants of IRS‐1 to phosphorylated and unphosphorylated IGF‐1R were (8.06±5.18)×109 M−1 and (9.81±4.61)×108 M−1, respectively.

[1]  D. Altschuh,et al.  Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. , 1992, Immunology letters.

[2]  C. Fong,et al.  Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. , 1999, Biochimica et biophysica acta.

[3]  M. Jansson,et al.  Characterization of Ligand Binding of a Soluble Human Insulin-like Growth Factor I Receptor Variant Suggests a Ligand-induced Conformational Change* , 1997, The Journal of Biological Chemistry.

[4]  D. O'Shannessy,et al.  Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction. , 1992, Analytical biochemistry.

[5]  D. Leroith,et al.  The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis (*) , 1995, The Journal of Biological Chemistry.

[6]  P. Cuatrecasas,et al.  Monoclonal antibodies to receptors for insulin and somatomedin-C. , 1983, The Journal of biological chemistry.

[7]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[8]  J. Olefsky,et al.  Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.

[9]  E. Van Obberghen,et al.  Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.

[10]  T. Kirchhausen,et al.  Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2 , 1995, Current Biology.

[11]  B. R. Dey,et al.  Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. , 1996, Molecular endocrinology.

[12]  D. Leroith Editorial: Insulin-Like Growth Factor I Receptor Signaling-Overlapping or Redundant Pathways? , 2000, Endocrinology.

[13]  Magnus Malmqvist,et al.  Biospecific interaction analysis using biosensor technology , 1993, Nature.

[14]  G. Lienhard,et al.  The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[15]  M. Jansson,et al.  Binding affinities of insulin‐like growth factor‐I (IGF‐I) fusion proteins to IGF binding protein 1 and IGF‐I receptor are not correlated with mitogenic activity , 1997, FEBS letters.

[16]  C. Roberts,et al.  Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). , 1993, The Journal of biological chemistry.

[17]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[18]  M. White,et al.  The IRS-1 signaling system. , 1994, Trends in biochemical sciences.

[19]  E. Van Obberghen,et al.  Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system. , 1996, Endocrinology.

[20]  M. Kasuga,et al.  A biosensor approach to probe the structure and function of the p85 alpha subunit of the phosphatidylinositol 3-kinase complex. , 1993, The Journal of biological chemistry.

[21]  T. O’Neill,et al.  Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (*) , 1995, The Journal of Biological Chemistry.

[22]  R. Karlsson,et al.  Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. , 1994, Analytical biochemistry.

[23]  Y. Umezawa,et al.  An SPR-based screening method for agonist selectivity for insulin signaling pathways based on the binding of phosphotyrosine to its specific binding protein. , 2000, Analytical chemistry.

[24]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[25]  G. Magnusson,et al.  Lactose repressor-operator DNA interactions: kinetic analysis by a surface plasmon resonance biosensor. , 1993, Analytical biochemistry.

[26]  R. Karlsson,et al.  Detection of antigen—antibody interactions by surface plasmon resonance. Application to Epitope Mapping , 1990, Journal of molecular recognition : JMR.

[27]  Ling-mei Wang,et al.  Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[28]  C. Kahn,et al.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.

[29]  B. Persson,et al.  Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins , 1991 .

[30]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[31]  E. Van Obberghen,et al.  Evidence for a Differential Interaction of SHC and the Insulin Receptor Substrate-1 (IRS-1) with the Insulin-like Growth Factor-I (IGF-I) Receptor in the Yeast Two-hybrid System (*) , 1995, The Journal of Biological Chemistry.

[32]  A. Ullrich,et al.  A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. , 1992, The Journal of biological chemistry.